Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
.
Objective and design:
We examine whether lipoxin A
4
4 (LXA
4
) inhibits production of interleukins (ILs) in endothelial cells and what signal pathway might participate in the actions of LXA
4
.
Methods:
Cultured pulmonary microvascular endothelial cells (PMVEC) were treated with lipopolysaccharide (LPS), with or without preincubation with LXA
4
.
Results:
The results showed that LPS induced production of IL-1β, IL-6 and IL-8 in rat PMVEC, upregulated the expressions of myeloid differentiation factor 88 (MyD88), phosphorylated p38 and p42/44 mitogen-activated protein kinase (MAPK), phosphorylated phosphoinositide 3-kinase (PI3-K), DNA-binding activities of nuclear factor-κ B (NF-κB) and activator protein-1(AP-1). The blockade of p38 MAPK, p42/44 MAPK, PI3-K, NF-κB or AP-1 partially inhibited production of IL-1β, IL-6 and IL-8 stimulated by LPS, respectively. LXA
4
significantly inhibited LPS-stimulated secretion of protein and expressions of mRNA of IL-1β, IL-6 and IL-8, activation of p38 MAPK, p42/44 MAPK, PI3-K, NF-κB and AP-1 but not MyD88 in PMVEC.
Conclusions:
LXA
4
inhibits synthesis of IL-1β, IL-6 and IL-8 in PMVEC and this antagonism is related to PI3-K, p38 and p42/44 MAPK, NF-κB and AP-1 pathway-dependent signal transduction.